Regenron

A COVID-19 Vaccine is set to start late stage trials where they can test to see how well the the drug works to not only treat, but prevent the coronavirus. Biotech company Regeneron has said that they have a unique double antibody solution during a press release on Monday. This vaccine is unique because it […]